title: Levodopa reduces risk factors for vascular disease in parkinsonian patients.
authors.forename: Giulio
authors.initials: G
authors.lastname: Scigliano
authors.forename: Gabriele
authors.initials: G
authors.lastname: Ronchetti
authors.forename: Floriano
authors.initials: F
authors.lastname: Girotti
authors.forename: Massimo
authors.initials: M
authors.lastname: Musicco
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D050356:Lipid Metabolism / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D012189:Retrospective Studies; D012307:Risk Factors; D014652:Vascular Diseases / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*
chemical_list: D000978:Antiparkinson Agents; D001786:Blood Glucose; D007980:Levodopa; D002784:Cholesterol